TB-500 (Thymosin Beta-4) · Research brief

TB 500 Bulk: Purity, Pricing and Lab Supply Explained

Real Peptides Research TeamEditorial

Updated September 29, 20269 min read

58 WORDS

Short answer

Two vials labelled TB-500 can hold two different molecules, and neither supplier is necessarily lying. One contains full-length thymosin beta-4 (Tβ4), a 43-amino-acid peptide of roughly 4.9 kDa. The other contains a short synthetic fragment built around the LKKTETQ actin-binding motif. That ambiguity, not the per-milligram discount, is the most expensive variable in any TB 500 bulk order.

Key takeaways

Material sold as TB-500 may be full-length thymosin beta-4 (43 amino acids, approximately 4.9 kDa) or a short synthetic fragment built on the LKKTETQ actin-binding motif, and the certificate of analysis is the only way to tell.
HPLC purity and net peptide content measure different things, so cost per milligram of actual peptide is the only valid way to compare TB 500 price across suppliers.
Residual trifluoroacetate counterions and moisture account for the gap between gross vial mass and net peptide mass in lyophilised powders.
Lot-matched TB 500 bulk ordering removes batch-to-batch variability from a study, which usually outweighs the per-vial saving.
Lyophilised peptide belongs at −20°C sealed and dry; reconstituted solution belongs at 2–8°C and should be aliquoted to avoid repeated freeze-thaw cycles.
BPC 157 TB500 bulk orders placed with one supplier keep analytical methods and lot documentation aligned, which matters when results need reconciling months later.

Our team fields more questions about sequence identity than about price, and the two are tied together. Labs that compare quotes without comparing certificates of analysis usually end up comparing different compounds.

What does buying TB 500 bulk mean for a research laboratory?

Buying TB 500 bulk means ordering multiple vials of lyophilised thymosin beta-4, or its synthetic fragment, drawn from a single synthesis lot and covered by one certificate of analysis. Lot-matched material removes batch-to-batch variability from the experimental design, which affects data quality more than the volume discount does.

Here's where buyers get caught. The TB 500 price you're quoted rarely scales cleanly with milligrams, because the figure printed on a vial is gross powder mass, not net peptide mass. This article covers what's actually in the vial, how TB 500 bulk pricing is built from purity, peptide content and synthesis length, and how BPC 157 TB500 bulk orders should be documented, shipped and stored.

What's actually in the vial when you order in volume

Thymosin beta-4 is a 43-amino-acid, highly conserved intracellular peptide whose primary described function is actin sequestration. It binds monomeric G-actin and regulates its availability for polymerisation into F-actin filaments, which is why the published literature explores it in cytoskeletal, corneal, dermal and cardiac repair models. The actin-binding region sits at residues 17–23, the LKKTETQ motif, and a separate N-terminal fragment, Ac-SDKP, is studied independently for antifibrotic activity. Research suggests these fragments behave differently from the parent molecule, so they are not interchangeable inputs.

Most material sold as TB-500 in the research market is the synthetic fragment rather than the full 43-mer. Neither is wrong. What matters is that your certificate of analysis states the amino-acid sequence and the mass-spectrometry-confirmed molecular weight, not just a trade name. A mass spec peak near 4.9 kDa indicates full-length Tβ4. A peak in the 800–900 Da range indicates a short acetylated fragment. If the COA shows purity but no sequence or MW confirmation, you cannot verify identity, only that whatever is in there is clean.

This is the quiet failure mode in TB 500 bulk purchasing: labs replicate a published protocol using the full-length peptide, buy the fragment because it's cheaper per milligram, and then can't reconcile their results with the source paper. Real Peptides publishes sequence and analytical data for TB-500 (thymosin beta-4) so identity is verifiable before the order rather than after.

What drives TB 500 price beyond milligrams per vial

HPLC purity and net peptide content are two different measurements, and conflating them is the most common costing error we see. HPLC purity tells you what proportion of the peptide present is the target sequence. Net peptide content tells you what proportion of the total powder mass is peptide at all. The remainder is typically trifluoroacetate counterions left from purification plus residual moisture, both of which weigh something and neither of which is peptide.

So a vial labelled 10mg at 98% HPLC purity can still contain meaningfully less than 10mg of actual peptide, because that 98% describes the peptide fraction, not the fill. Two suppliers quoting the same nominal milligrams at the same TB 500 price are not necessarily selling the same quantity of compound. The only honest comparison is cost per milligram of net peptide, which requires a peptide content assay on the certificate.

Synthesis length is the second price driver. Solid-phase synthesis of a 43-residue chain requires far more coupling cycles, more purification, and produces lower crude yield than a 7-residue fragment, which is why quotes for material labelled identically can differ several-fold. Bulk discounts exist because one synthesis run, one preparative HPLC purification and one QC panel get amortised across more vials. That's the genuine economics of TB 500 bulk, and it's also why a supplier offering deep discounts on a single vial is telling you something about their batch sizes.

Ordering BPC-157 and TB-500 together, and handling what arrives

The BPC 157 TB500 bulk pairing is one of the most searched supplier combinations, and the reason is mechanistic separation rather than synergy marketing. BPC-157 is a pentadecapeptide, 15 amino acids, derived from a partial sequence of a protein isolated from gastric juice, and the literature around it centres on angiogenic and tendon-fibroblast pathways. Thymosin beta-4 acts on the actin cytoskeleton. Investigators studying tissue repair models frequently want both arms in the same design, which makes lot-matched co-ordering across compounds a documentation problem as much as a purchasing one.

Order both from one supplier, in one shipment, with certificates issued against the specific lots you received. Cross-supplier sourcing means cross-supplier analytical methods, and reconciling two different HPLC gradient protocols after the fact is not a good use of anyone's week. You can review sequence and purity documentation for BPC-157 alongside the TB-500 data, and every lot we ship has a corresponding certificate of analysis.

Handling is where bulk quantities actually get destroyed. Lyophilised peptide powder should be held at −20°C, sealed, protected from light and moisture, because these sequences are hygroscopic and atmospheric water entering a vial begins hydrolytic degradation you cannot see. Once reconstituted in sterile solvent, the solution belongs at 2–8°C and should be aliquoted to avoid repeated freeze-thaw cycles, each of which introduces mechanical stress on the peptide bond structure. All compounds discussed here are research-use-only materials, not FDA-approved drugs, and are not intended for human or veterinary consumption. Any study design involving animal subjects should be reviewed with a licensed veterinarian and the relevant institutional animal care committee before work begins.

TB 500 bulk formats compared: vials, purity and paperwork

Different ordering formats solve different problems, and the cheapest unit price rarely belongs to the format that fits the experiment. This table maps what each format delivers in practice.

Ordering format	What you receive	Documentation typically provided	Best suited for	Bottom Line
Single vial (5–10mg)	One lyophilised vial from whatever lot is current	COA for that lot, sequence and HPLC purity	Pilot work, method development, solvent and stability testing	Highest cost per milligram, but the right call before committing to a full study design
Lot-matched multi-vial bulk	Several vials drawn from one synthesis and one purification run	Single COA covering the entire batch, including peptide content	Multi-arm or multi-timepoint studies where variability must be controlled	The default for serious work, because one variable is eliminated across every vial
Paired compound bulk (BPC 157 TB500 bulk)	Both compounds shipped together, each lot-documented	Separate COAs issued under one supplier's analytical method	Comparative tissue-repair models running both agents	Simplifies reconciliation later; mixing suppliers creates method mismatch you'll pay for in analysis time
Large-scale or custom synthesis	Gram-scale material synthesised to order	Full analytical panel including MS identity and residual solvent data	Long-running programmes with predictable consumption	Lowest cost per milligram, but lead times are measured in weeks, not days

What If: TB 500 bulk sourcing scenarios

What if the COA lists a molecular weight I wasn't expecting?

Stop and confirm the sequence line before opening anything. A mass-spectrometry result near 4.9 kDa points to full-length Tβ4, while a result under 1 kDa points to an acetylated short fragment. Neither is a defect, but substituting one for the other mid-study breaks comparability with the literature you're referencing, and you won't be able to unpick it in the data afterwards.

What if my shipment arrives warm or the cold pack has fully thawed?

Lyophilised peptide is considerably more tolerant of brief ambient excursions than reconstituted solution, but document the condition on arrival and contact the supplier before use. The genuine risk with warm transit isn't heat alone, it's condensation forming inside the vial when a cold container warms, because moisture ingress initiates hydrolysis in a powder that's meant to stay bone dry.

What if two vials from the same order look different?

A collapsed, flattened or glassy cake alongside a fluffy white one usually reflects lyophilisation cycle variation rather than degradation, and it doesn't automatically indicate a problem. That said, photograph both and raise it with the supplier, because cake collapse can also signal a vacuum seal failure. Consistent appearance across a lot is one of the practical benefits of small-batch synthesis.

What if I need BPC-157 and TB-500 but the lots don't match in date?

Different synthesis dates across two different compounds is normal and not a problem in itself. What you need is each lot individually documented, with its own certificate, so the analytical record matches the vials physically in your freezer. Record lot numbers against experimental arms at the point of receipt rather than later.

The blunt truth about cheap bulk peptide pricing

Let's be direct about this: a TB 500 bulk quote that undercuts the market by a wide margin is almost always explained by one of three things. It's the short fragment sold against full-length expectations, it's a vial with low net peptide content padded by salt and moisture, or it's material with no lot-specific analytical data behind it. None of those are fraud in a strict legal sense. All of them mean you're buying a different thing than you thought. The information here is educational, and purchasing decisions for regulated research materials should follow your institution's own procurement and QC standards.

Labs comparing options can review sequence and purity data across the TB-500 information page, the BPC-157 capsule format, Thymosin Alpha-1, and the wider research peptide catalog, with lot-level certificates available for every compound listed.

TB 500 bulk buying rewards the boring discipline nobody advertises: read the sequence, check the peptide content assay, match the lot, log the numbers on arrival. The compounds themselves are remarkably stable when handled properly and remarkably fragile when they aren't, and the difference almost never shows up as something you can see in the vial. It shows up eighteen months later, when a result won't replicate and the only record of what you actually used is a label that said TB-500 and nothing else.

References

Peer-reviewed sources on TB-500 (Thymosin Beta-4) indexed in PubMed, listed for research context. Real Peptides supplies TB-500 (Thymosin Beta-4) for laboratory research use only.

Thymosin β4 alleviates sepsis-associated acute kidney injury by suppressing MAPK signaling pathway. Clinical science (London, England : 1979), 2026. PMID 42417058. doi:10.1042/CS20261084
Sprayable bioadhesive microcarriers loaded with Tβ4-Engineered ADSC exosomes for diabetic wound healing. Bioactive materials, 2026. PMID 42383202. doi:10.1016/j.bioactmat.2026.06.024
Thymosin beta 4 as an Alzheimer disease intervention target identified using human brain organoids. Stem cell reports, 2025. PMID 40816274. doi:10.1016/j.stemcr.2025.102601
Mechanistic study of the Tβ4/SLC7A11 signaling pathway regulating breast cancer evolution. Cellular signalling, 2025. PMID 40912522. doi:10.1016/j.cellsig.2025.112111
Thymosin β4 Regulates Tissue Inflammatory Response in Mouse Nonalcoholic Fatty Liver Disease by Promoting Macrophage M2-Type Polarization. Journal of inflammation research, 2025. PMID 40322536. doi:10.2147/JIR.S492814
Injectable Thymosin β4-Modified Hyaluronic Acid Hydrogel with Exosomes for Stem Cell Homing and Neuronic-Angiogenic-Osteogenic Coupled Cranial Repair. ACS nano, 2025. PMID 40528381. doi:10.1021/acsnano.4c10386
Secreted Expression of Thymosin β4 from Pinctada fucata in Pichia pastoris and Its Biological Activity. Biology, 2025. PMID 40427742. doi:10.3390/biology14050553
Thymosin β4 and the anti-fibrotic switch. International immunopharmacology, 2023. PMID 36580759. doi:10.1016/j.intimp.2022.109628

Build a pack

Researching more than one compound?

Build a multi-vial pack and the discount applies automatically as you add vials.

Start a pack

Questions

TB 500 bulk orders are drawn from a single synthesis and purification run, so every vial carries the same purity, peptide content and lot number under one certificate of analysis. Single vials come from whatever lot is current, which means two separate orders may differ analytically. For multi-arm or multi-timepoint studies, lot matching removes a variable you'd otherwise have to control for statistically.

Full-length thymosin beta-4 is a 43-amino-acid peptide of approximately 4.9 kDa that sequesters monomeric G-actin and regulates its polymerisation into F-actin. The material commonly sold as TB-500 is often a short synthetic fragment built around the LKKTETQ actin-binding motif at residues 17–23. They are different molecules with different molecular weights, so the certificate of analysis sequence line is the only reliable way to confirm which one you have.

Three factors explain most of the spread. Synthesis length comes first, since a 43-residue chain needs far more coupling cycles and purification than a 7-residue fragment. Net peptide content comes second, because trifluoroacetate counterions and residual moisture add mass without adding peptide. Analytical depth comes third, as lot-specific mass spectrometry and peptide content assays cost money that no-documentation suppliers simply don't spend.

Yes, and there's a practical reason to. Ordering both compounds from one supplier means both certificates are issued under the same analytical methodology, so purity figures are directly comparable rather than generated by two different HPLC gradient protocols. Real Peptides supplies both compounds for laboratory research with lot-specific certificates for each.

Lyophilised peptide powder should be kept sealed at −20°C, protected from light and moisture. These sequences are hygroscopic, meaning atmospheric water entering the vial begins hydrolytic degradation that isn't visible in the cake. Once reconstituted in sterile solvent, solution is held at 2–8°C and aliquoted so repeated freeze-thaw cycles don't stress the peptide structure.

No. TB-500 and thymosin beta-4 are not FDA-approved drug products and are supplied strictly as research-use-only materials for laboratory investigation. They are not intended for human or veterinary consumption, and any study involving animal subjects should be reviewed with a licensed veterinarian and the appropriate institutional review body beforehand.

At minimum it should list the amino-acid sequence, mass-spectrometry-confirmed molecular weight, HPLC purity percentage with the chromatogram, net peptide content, and the specific lot number matching the vials shipped. Purity alone is insufficient, because it only describes how clean the peptide fraction is, not what the peptide is or how much of the powder mass it represents.

Not on its own. A vial at 99% HPLC purity with low net peptide content can deliver less actual peptide than a 97% vial with a high peptide content assay, because the purity figure describes the peptide fraction rather than the total fill. Cost per milligram of net peptide is the comparison that matters, and it requires both numbers to calculate.

The main risks are identity substitution, where a short fragment is supplied against full-length expectations, and quantity shortfall from unmeasured salt and moisture content. Without lot-specific data there's no way to trace a problematic batch or reconcile anomalous results against the material used. Undocumented material also creates reproducibility gaps that surface long after the work is finished.

Stability depends on solvent, concentration, storage temperature and how many times the vial is opened, so no universal figure applies. Refrigerated storage at 2–8°C with aliquoting to avoid repeated freeze-thaw is standard laboratory practice for reconstituted peptide solutions. Labs running long protocols should verify stability under their own conditions rather than relying on a generic shelf-life number.

Variation in cake appearance, from fluffy white to collapsed or glassy, usually reflects differences in the lyophilisation cycle rather than degradation of the compound. It can occasionally indicate a vacuum seal failure, which is worth raising with the supplier and photographing before use. Consistent cake appearance across a lot is one of the practical markers of tightly controlled small-batch synthesis.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA